Cargando…
Cancer‐associated POT1 mutations lead to telomere elongation without induction of a DNA damage response
Mutations in the shelterin protein POT1 are associated with chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, angiosarcoma, melanoma, and other cancers. These cancer‐associated POT1 (caPOT1) mutations are generally heterozygous, missense, or nonsense mutations occurring throughout the POT1 readi...
Autores principales: | Kim, Won‐Tae, Hennick, Kelsey, Johnson, Joshua, Finnerty, Brendan, Choo, Seunga, Short, Sarah B, Drubin, Casey, Forster, Ryan, McMaster, Mary L, Hockemeyer, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204863/ https://www.ncbi.nlm.nih.gov/pubmed/33934394 http://dx.doi.org/10.15252/embj.2020107346 |
Ejemplares similares
-
Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita
por: Choo, Seunga, et al.
Publicado: (2022) -
Telomere length set point regulation in human pluripotent stem cells critically depends on the shelterin protein TPP1
por: Boyle, John M., et al.
Publicado: (2020) -
Pot1b
(−/−) tumors activate G-quadruplex-induced DNA damage to promote telomere hyper-elongation
por: Takasugi, Taylor, et al.
Publicado: (2023) -
TINF2 is a haploinsufficient tumor suppressor that limits telomere length
por: Schmutz, Isabelle, et al.
Publicado: (2020) -
Trimethylaluminum-mediated one-pot peptide elongation
por: Hattori, Tomohiro, et al.
Publicado: (2023)